Model Number MSB_UNK_HDWR_CDH |
Device Problem
Loosening of Implant Not Related to Bone-Ingrowth (4002)
|
Patient Problems
Pain (1994); Cramp(s) /Muscle Spasm(s) (4521); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 03/09/2023 |
Event Type
Injury
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider, clinical study) regarding a patient who was implanted with screws due to stenosis.It was reported that upon evaluation of arthrodesis status on the 1 year lumbar spine ct, it was noted that subject had l4 screw loosening.Patient had pseudoarthrosis chronic pain management and continues to report lower back spasms.Screw removal is planned for the loose screws.Outcome status - not recovered/not resolved severity of ae - moderate site related assessment - possibly related with capstone peek spinal system implant, tlif grafting material, and procedure sponsor assessment : sponsor assessment: possible related to the tlif graft material, to the capstone peek and probable to the post supp fix system probably related with posterior supplemental fixation system there were no further complications reported regarding the event.
|
|
Manufacturer Narrative
|
Outcomes attributed to adverse event : other - revision surgery is planned.Product identifiers are unknown.Adverse event problem: annex e2402- pseudarthrosis.Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Update received sponsor assessment: possible related to the capstone peek and to the post supp fix system the surgery hasn't been scheduled yet and the patient may not go through with the revision.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
2023-07-06, update received interventions : action subtype: surgical treatment action result: yes outcome status: recovering/resolving add surgical proc date - 11:(b)(6) 2023 details surg proc - 11: l4-s2 instrumentation (prior l4-s1)redo/posterior lateral fusion with infuse l4-s1 is the additional surgical procedure an elective removal - n does the additional surgical procedure involve a spinal level - y add.Surg: if yes, levels involved - l4-l5, l5-s1, other spinal level does the additional surgical procedure involve an explant related to the study procedure - y cause of explantation - : loose hardware findings for explantation - severely loose screws l4,some loosening l5-s1 findings at add.Surg - : removal of posterior segmental instrumentation (solera pedical screws, l4-s1 were removed)upsizing of screws biopsies taken -: n medical intervention: y site related assessment additionl surgery had causal relationship with capstone peek spinal system implant, tlif grafting material, procedure and possibly related to posterior supplemental fixation system (b)(6) 2023 , update received findings for explantation - 11: severely loose screws l4,some loosening l5-s1 findings at add.Surg - 11: revision and removal of posterior segmental instrumentation(medtronic 6 solera pedical screws,2 rods and 1 cross connector was explanted.(b)(6) 2023 , update received details surg proc - 11: l4-s2 fusion (surgical revision) subject had prior l4-s1 with screw loosening.
|
|
Manufacturer Narrative
|
B5.Desc evt problem updated.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Outcome status- recovered/resolved outcome date- (b)(6) 2023.
|
|
Search Alerts/Recalls
|
|